Cedric Hermans Presenting FRONTIER2 Data on Mim8 in Adolescents and Adults with Haemophilia A
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
“What matters most – patient reported outcomes at ASH Cedric Hermans presenting FRONTIER2 data on Mim8 in adolescents and adults with haemophilia A (with and without inhibitors) – and it’s a reminder of what we should have been measuring all along. Not just bleeding control, but how patients actually live.
The numbers:
Treatment burden – 46-62% hit clinically meaningful improvement
Joint pain – 59-95% saw relief depending on where they started
Physical activity – jumped across all groups, 100% in the on-demand cohort
Physical functioning – +4 to +17.6 on the PedsQL scale
But the real story?
88-98% of patients prefer Mim8 over what they were taking before.
Three different PRO measures (Hemo-TEM, PedsQL, JPRS) all pointed the same way. Better experience, better function, less pain. And it held up over the full 52 weeks.
QW vs QM dosing showed similar PRO benefits – patients actually have flexibility that works.
When you ask patients what matters: It’s your life back. Less burden. Less pain. More activity. Those preference numbers speak for themselves”
Discover the latest in Hemostasis Today.
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause